THE Consumers Health Forum
and the Australian Healthcare
and Hospitals Association will next
month host a Sydney workshop on
consumer engagement in innovation
and value creation in health care.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 08 Jul 16 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 08 Jul 16
CONSUMERS and health professionals are advised that Biogen Australia, in consultation with the Therapeutic Goods Administration (TGA), will withdraw multiple sclerosis therapy Zinbryta (daclizumab) from the Australian market following a review of cases of serious inflammatory brain disorders in Europe (PD 05 Mar).